Attendo AB (publ)

OM:ATT Stock Report

Market Cap: SEK 7.9b

Attendo Valuation

Is ATT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ATT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ATT (SEK51.2) is trading below our estimate of fair value (SEK328.62)

Significantly Below Fair Value: ATT is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ATT?

Key metric: As ATT is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ATT. This is calculated by dividing ATT's market cap by their current earnings.
What is ATT's PE Ratio?
PE Ratio19.7x
EarningsSEK 400.00m
Market CapSEK 7.88b

Price to Earnings Ratio vs Peers

How does ATT's PE Ratio compare to its peers?

The above table shows the PE ratio for ATT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average21.7x
AMBEA Ambea
13.5x11.5%SEK 8.2b
HUM Humana
14.9x44.7%SEK 1.8b
ARJO B Arjo
18.4x23.3%SEK 9.3b
RAY B RaySearch Laboratories
40.1x24.1%SEK 7.0b
ATT Attendo
19.7x23.7%SEK 7.9b

Price-To-Earnings vs Peers: ATT is good value based on its Price-To-Earnings Ratio (19.7x) compared to the peer average (21.7x).

Price to Earnings Ratio vs Industry

How does ATT's PE Ratio compare vs other companies in the European Healthcare Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
ATT 19.7xIndustry Avg. 18.2xNo. of Companies9PE01020304050+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: ATT is expensive based on its Price-To-Earnings Ratio (19.7x) compared to the European Healthcare industry average (18.5x).

Price to Earnings Ratio vs Fair Ratio

What is ATT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ATT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio19.7x
Fair PE Ratio26.5x

Price-To-Earnings vs Fair Ratio: ATT is good value based on its Price-To-Earnings Ratio (19.7x) compared to the estimated Fair Price-To-Earnings Ratio (26.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ATT forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentSEK 51.20
SEK 61.00
+19.1%
1.6%SEK 62.00SEK 60.00n/a2
Dec ’25SEK 48.60
SEK 61.00
+25.5%
1.6%SEK 62.00SEK 60.00n/a2
Nov ’25SEK 47.60
SEK 62.50
+31.3%
4.0%SEK 65.00SEK 60.00n/a2
Oct ’25SEK 47.75
SEK 62.00
+29.8%
4.8%SEK 65.00SEK 59.00n/a2
Sep ’25SEK 48.10
SEK 59.50
+23.7%
9.2%SEK 65.00SEK 54.00n/a2
Aug ’25SEK 46.05
SEK 59.50
+29.2%
9.2%SEK 65.00SEK 54.00n/a2
Jul ’25SEK 43.70
SEK 57.50
+31.6%
13.0%SEK 65.00SEK 50.00n/a2
Jun ’25SEK 42.50
SEK 52.50
+23.5%
4.8%SEK 55.00SEK 50.00n/a2
Jul ’24SEK 31.60
SEK 47.50
+50.3%
5.3%SEK 50.00SEK 45.00SEK 43.702
Jun ’24SEK 32.60
SEK 47.50
+45.7%
5.3%SEK 50.00SEK 45.00SEK 42.502
May ’24SEK 36.35
SEK 47.50
+30.7%
5.3%SEK 50.00SEK 45.00SEK 41.802
Apr ’24SEK 29.70
SEK 43.00
+44.8%
16.3%SEK 50.00SEK 36.00SEK 40.802
Mar ’24SEK 24.50
SEK 42.00
+71.4%
19.0%SEK 50.00SEK 34.00SEK 37.302
Feb ’24SEK 26.40
SEK 42.00
+59.1%
19.0%SEK 50.00SEK 34.00SEK 40.752
Jan ’24SEK 24.22
SEK 42.00
+73.4%
19.0%SEK 50.00SEK 34.00SEK 36.102
Dec ’23SEK 25.48
SEK 42.00
+64.8%
19.0%SEK 50.00SEK 34.00SEK 35.302

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 06:35
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Attendo AB (publ) is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel ThorssonABG Sundal Collier
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Hans Bjorn BostromCredit Suisse